Search details
1.
Long-term Experience and Outcomes of Programmatic Antiretroviral Therapy for Human Immunodeficiency Virus Type 2 Infection in Senegal, West Africa.
Clin Infect Dis
; 72(3): 369-378, 2021 02 01.
Article
in English
| MEDLINE | ID: mdl-33527119
2.
Nonlinear multiple imputation for continuous covariate within semiparametric Cox model: application to HIV data in Senegal.
Stat Med
; 32(26): 4651-65, 2013 Nov 20.
Article
in English
| MEDLINE | ID: mdl-23712767
3.
Long-term effectiveness and safety of didanosine combined with lamivudine and efavirenz or nevirapine in antiretroviral-naive patients: a 9-year cohort study in Senegal.
Trop Med Int Health
; 16(2): 217-22, 2011 Feb.
Article
in English
| MEDLINE | ID: mdl-21087377
4.
African voices and leadership is imperative for the global AIDS response.
Pan Afr Med J
; 32: 87, 2019.
Article
in English
| MEDLINE | ID: mdl-31223378
5.
No evidence for recombination between HIV type 1 and HIV type 2 within the envelope region in dually seropositive individuals from Senegal.
AIDS Res Hum Retroviruses
; 20(9): 958-63, 2004 Sep.
Article
in English
| MEDLINE | ID: mdl-15585083
6.
Molecular epidemiology of dual HIV-1/HIV-2 seropositive adults from Senegal, West Africa.
AIDS Res Hum Retroviruses
; 19(7): 575-84, 2003 Jul.
Article
in English
| MEDLINE | ID: mdl-12908935
7.
The fourth HIV epidemic.
Lancet Infect Dis
; 18(4): 379-380, 2018 04.
Article
in English
| MEDLINE | ID: mdl-29582762
8.
Mortality, AIDS-morbidity, and loss to follow-up by current CD4 cell count among HIV-1-infected adults receiving antiretroviral therapy in Africa and Asia: data from the ANRS 12222 collaboration.
J Acquir Immune Defic Syndr
; 62(5): 555-61, 2013 Apr 15.
Article
in English
| MEDLINE | ID: mdl-23274931
9.
Modeling CD4+ cell count increase over a six-year period in HIV-1-infected patients on highly active antiretroviral therapy in Senegal.
Am J Trop Med Hyg
; 80(6): 1047-53, 2009 Jun.
Article
in English
| MEDLINE | ID: mdl-19478274
10.
Lipodystrophy and metabolic disorders in HIV-1-infected adults on 4- to 9-year antiretroviral therapy in Senegal: a case-control study.
J Acquir Immune Defic Syndr
; 51(2): 224-30, 2009 Jun 01.
Article
in English
| MEDLINE | ID: mdl-19339897
11.
Universal health coverage and HIV in resource-constrained countries: a critical juncture for research and action.
AIDS
; 27(14): 2173-5, 2013 Sep 10.
Article
in English
| MEDLINE | ID: mdl-24157902
12.
Antiretroviral drugs in Africa: a public health versus a market approach.
J Acquir Immune Defic Syndr
; 63(2): e74-6, 2013 Jun 01.
Article
in English
| MEDLINE | ID: mdl-23666139
13.
Change over time of mortality predictors after HAART initiation in a Senegalese cohort.
Eur J Epidemiol
; 23(3): 227-34, 2008.
Article
in English
| MEDLINE | ID: mdl-18197359
14.
A 84-month follow up of adherence to HAART in a cohort of adult Senegalese patients.
Trop Med Int Health
; 12(10): 1191-8, 2007 Oct.
Article
in English
| MEDLINE | ID: mdl-17956501
15.
Equal plasma viral loads predict a similar rate of CD4+ T cell decline in human immunodeficiency virus (HIV) type 1- and HIV-2-infected individuals from Senegal, West Africa.
J Infect Dis
; 185(7): 905-14, 2002 Apr 01.
Article
in English
| MEDLINE | ID: mdl-11920314
Results
1 -
15
de 15
1
Next >
>>